TRAF4 Inhibitors

TRAF4 inhibitors constitute a diverse group of chemicals that selectively modulate the activity of TRAF4, a crucial signaling adaptor protein. One notable inhibitor is BAY 11-7082, which indirectly inhibits TRAF4 by suppressing NF-κB signaling. By preventing IκBα phosphorylation and degradation, BAY 11-7082 interferes with the NF-κB pathway, leading to indirect inhibition of TRAF4 and modulation of downstream cellular processes. SM08346, a direct inhibitor, disrupts the interaction between TRAF4 and the TLR4 receptor. This interference with the TLR4/TRAF4 signaling pathway directly inhibits TRAF4 and hampers downstream signaling events, impacting cellular responses associated with TRAF4 activation. NSC 131463 indirectly inhibits TRAF4 by targeting receptor tyrosine kinases (RTKs), modulating downstream signaling pathways and influencing cellular processes associated with TRAF4 activation.

IKK-16 inhibits TRAF4 indirectly by blocking IκB kinases (IKKs). Through IKK inhibition, IKK-16 suppresses NF-κB signaling, leading to indirect inhibition of TRAF4 and modulation of cellular responses. NBD peptide disrupts the TRAF4/TRIF interaction, indirectly inhibiting TRAF4 and influencing downstream signaling events. Celastrol indirectly inhibits TRAF4 by suppressing the HSP90-Cdc37 chaperone complex, affecting TRAF4 stability and function. SMER28 promotes autophagic degradation, indirectly inhibiting TRAF4 by influencing its turnover. JSH-23 indirectly inhibits TRAF4 by suppressing NF-κB signaling, preventing the nuclear translocation of p65. SDZ-62-434 targets the JAK/STAT pathway, indirectly inhibiting TRAF4 by inhibiting JAK2 and modulating downstream signaling events. CAY10657 disrupts the TAK1/TAB complex, leading to indirect inhibition of TRAF4 and modulation of cellular responses. QNZ inhibits TRAF4 indirectly by blocking NF-κB activation, suppressing the phosphorylation of IκBα. SC75741 targets the JAK/STAT pathway, indirectly inhibiting TRAF4 by inhibiting JAK2 and influencing downstream signaling events. Collectively, these inhibitors offer a valuable toolkit for researchers to selectively modulate TRAF4 activity, providing insights into the intricate regulation of cellular responses associated with TRAF4 activation.